Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584 Stock Report

Market Cap: CN¥2.7b

Nanjing Hicin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 300584?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme1,088,7300.907%
Institutions1,511,6671.26%
General Public45,440,16037.9%
Individual Insiders71,959,44360%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 20 shareholders own 62.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
42.1%
Yu Ping Cao
50,491,306CN¥1.1b0%no data
9.98%
Xiao Qun Jiang
11,973,913CN¥266.7m0%no data
5%
Xiao Quan Liu
5,999,908CN¥133.6m-1.52%no data
1.67%
Meiqiang Yan
2,007,412CN¥44.7m0%no data
0.91%
Nanjing Hicin Pharmaceutical Co., Ltd., ESOP
1,088,730CN¥24.2m0%no data
0.48%
Jin Yuan Jiang
577,700CN¥12.9m0%no data
0.43%
Huatai-PineBridge Fund Management Co., Ltd.
515,400CN¥11.5m0%no data
0.38%
Yuping Cao
456,900CN¥10.2m0%no data
0.36%
Xiaomin Yao
435,104CN¥9.7m0%no data
0.29%
Barclays PLC Private Banking & Investment Banking Investment
351,386CN¥7.8m0%no data
0.28%
Huatai Securities (Shanghai) Asset Management Co., Ltd.
337,581CN¥7.5m0%0.06%
0.18%
CITIC-Prudential Fund Management Company Ltd.
211,900CN¥4.7m0%0.02%
0.049%
Western Leadbank Fund Management Co., Ltd.
59,200CN¥1.3m0%0.01%
0.021%
Manulife Asset Management
25,800CN¥574.6k0%no data
0.012%
Weicheng Liu
14,000CN¥311.9k0%no data
0.0067%
HFT Investment Management Co. Ltd. (Group)
8,000CN¥178.2k0%no data
0.0027%
Yan Luo
3,200CN¥71.4k0%no data
0.00092%
China Universal Asset Management Company Ltd.
1,100CN¥24.6k0%no data
0.00075%
China Asset Management Co. Ltd.
900CN¥20.0k0%no data
0.00033%
Guotai Asset Management Company Limited
400CN¥8.8k0%no data